Codiak BioSciences, Inc. Deferred Tax Assets, Valuation Allowance
Codiak BioSciences, Inc. had Deferred Tax Assets, Valuation Allowance of $93.09 million as of 2021-12-31, per its 10-K filed 2022-03-10.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsValuationAllowance · last filed 2022-03-10
- 2021-12-31: Deferred Tax Assets, Valuation Allowance $93.09M.
- 2020-12-31: Deferred Tax Assets, Valuation Allowance $80.76M.
- 2019-12-31: Deferred Tax Assets, Valuation Allowance $53.28M.
| Period end | Deferred Tax Assets, Valuation Allowance |
|---|---|
| 2021-12-31 | $93.09M 10-K · filed 2022-03-10 |
| 2020-12-31 | $80.76M 10-K · filed 2022-03-10 |
| 2019-12-31 | $53.28M 10-K · filed 2021-03-17 |